Prot: TNX-LVO-05: An Open-Label Rollover Study of Levosimendan in Patients with Pulmonary Hypertension with Heart Failure and Preserved Left Ventricular Ejection Fraction (PH-HFpEF)

Project: Research project

Project Details

StatusActive
Effective start/end date4/2/194/2/22

Funding

  • Tenax Therapeutics, Inc. (TNX-LVO-05)